Last reviewed · How we verify
NCT04470882
Use of Safety Behaviors in Exposure Therapy for Arachnophobia
NA trial testing Exposure with faded safety behaviors in Specific Phobia in 59 participants. Completed in 6 April 2020.
6 April 2020
Quick facts
| Lead sponsor | University of Nevada, Reno |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 59 |
| Start date | 28 February 2019 |
| Primary completion | 6 April 2020 |
| Estimated completion | 6 April 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Exposure with faded safety behaviors
- Exposure without safety behaviors
- Exposure with unfaded safety behaviors
Conditions studied
- Specific Phobia — all drugs for Specific Phobia →
- Arachnophobia — all drugs for Arachnophobia →
- Spider Phobia — all drugs for Spider Phobia →
Sponsor
University of Nevada, Reno
Who can join
18 and older, any sex, with Specific Phobia or Arachnophobia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study examines the impact of safety behaviors (i.e., unnecessary protective actions) on outcomes of exposure therapy for spider phobia. Researchers will compare exposure therapy with (a) no safety behaviors, (b) safety behaviors faded toward the end of treatment, and (c) unfaded safety behaviors.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04470882
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Specific Phobia
Currently open trials in the same condition.
- NCT07228143 — Stepped Care Treatment for Anxiety Resilience · NA · recruiting
- NCT06661460 — Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders · NA · recruiting
- NCT06942429 — Stepped Versus Stratified Care for Anxiety Disorders in Youth · NA · recruiting
- NCT06788119 — Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders · NA · recruiting
- NCT04563390 — Effectiveness of a Projection-based Augmented Reality Exposure System in Treating Cockroach Phobia. · NA · recruiting
Other University of Nevada, Reno trials
Trials by the same sponsor.
- NCT05908500 — Gathering Evidence on Best Practices for Lay Rescuer CPR Training · NA · not yet recruiting
- NCT06727786 — Serious Game to Teach Opioid Overdose Response · Phase 2 · not yet recruiting
- NCT03328455 — The Role of GABA-mediated Inhibition in Multisensory Temporal Processing & Postural Control in Older Adults · NA · not yet recruiting
- NCT06163599 — Reducing Mental Health Disparities Among Latinxs With a Telenovela Intervention · NA · recruiting
- NCT05918887 — Feasibility and Acceptability of Switching to E-cigarettes Among Cigarette Smokers Engaged in SUD Treatment · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04470882 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Nevada, Reno
- Last refreshed: 18 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04470882.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing